Alzheimer’s Study Finds Omega-3 Supplement, Stimulation Slow Cognitive Decline

Alzheimer’s Study Finds Omega-3 Supplement, Stimulation Slow Cognitive Decline

During the  8th International Conference on Clinical Trials for Alzheimer's Disease (CTAD) held in Barcelona, Spain, data from the MAPT study of older adults with memory lapses was presented. This study suggested that the combination of a multi-domain nutritional and stimulation intervention plus an omega-3 fatty acid supplementation slows cognitive decline in older adults, and particularly in individuals with mild cognitive impairment (MCI).

The MAPT trial, Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive Decline, was conceived to evaluate the combination of a supplement (docosahexaen
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *